Prevalence of hepatitis E virus RNA and antibodies in a cohort of kidney transplant recipients in Central Brazil

Int J Infect Dis. 2018 Apr:69:41-43. doi: 10.1016/j.ijid.2018.01.032. Epub 2018 Feb 10.

Abstract

Objective: To assess the prevalence of hepatitis E virus (HEV) RNA and antibodies among kidney transplant recipients (KTR) in Central Brazil. The presence of chronic HEV infection was also investigated.

Methods: A cohort study was conducted among 316 KTR treated at a referral center for kidney transplantation in Goiânia, Brazil. All serum samples were tested for the presence of HEV RNA (real-time PCR) and anti-HEV IgG/IgM (ELISA). Anti-HEV-positive samples were confirmed using an immunoblot test. HEV chronicity was investigated in a subgroup of patients with elevated alanine aminotransferase (ALT >40IU/l) through HEV RNA detection in additional serum samples collected 3 and 6 months apart.

Results: A seroprevalence of 2.5% (95% confidence interval 1.2-5.1%) was found for anti-HEV IgG. There was no difference in characteristics between the anti-HEV IgG seropositive and seronegative KTR groups. Anti-HEV IgM was detected in only one patient (0.3%). All KTR were negative for HEV RNA.

Conclusions: These results show that HEV infection is infrequent in KTR in Central Brazil, with low seroprevalence rates of past and recent infection, and also an absence of active and chronic HEV infections.

Keywords: Brazil; Hepatitis E virus; Kidney transplant recipients; Prevalence.

MeSH terms

  • Adult
  • Brazil / epidemiology
  • Cohort Studies
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Hepatitis Antibodies / blood
  • Hepatitis E / epidemiology*
  • Hepatitis E / immunology
  • Hepatitis E / virology*
  • Hepatitis E virus / genetics*
  • Hepatitis E virus / immunology*
  • Humans
  • Immunocompromised Host
  • Immunoglobulin G / blood
  • Immunoglobulin M / blood
  • Kidney Transplantation / adverse effects*
  • Kidney Transplantation / statistics & numerical data
  • Male
  • Middle Aged
  • Prevalence
  • RNA, Viral / blood
  • Seroepidemiologic Studies
  • Transplant Recipients* / statistics & numerical data

Substances

  • Hepatitis Antibodies
  • Immunoglobulin G
  • Immunoglobulin M
  • RNA, Viral